Non-Invasive Brain Stimulation for Working Memory Improvement
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to improve working memory using a non-invasive technique called transcranial alternating current stimulation (tACS). Gentle electrical currents target specific brain areas in people with epilepsy undergoing surgical evaluation. The trial divides participants into two groups: one receiving stimulation at a lower frequency and the other at a higher frequency. Eligible participants must be able to consent and have, or be scheduled for, surgically implanted electrodes as part of their epilepsy treatment. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance epilepsy treatment options.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this method is safe for improving working memory?
Research has shown that transcranial alternating current stimulation (tACS) is generally safe and easy to tolerate. In one study, young people with a specific genetic condition managed tACS well and experienced no major side effects. Other research indicates that tACS is safe and painless when used to alter brain activity patterns. It is considered safer than other brain stimulation methods. Overall, these findings suggest that tACS is a safe option for those considering participation in related studies.12345
Why are researchers excited about this trial?
Researchers are excited about the use of transcranial alternating current stimulation (tACS) for improving working memory because it offers a non-invasive approach that distinguishes itself from traditional treatments like medication or cognitive therapy. Unlike most treatments that rely on chemical interactions within the brain, tACS directly influences brain activity by applying electrical currents to specific regions. This method is unique as it targets neural oscillations, with the Theta Group using 4 Hz and the Beta Group using 23 Hz stimulation, potentially enhancing memory function more precisely and rapidly. The hope is that this innovative technique could lead to more effective and faster improvements in memory without the side effects commonly associated with medications.
What evidence suggests that this trial's treatments could be effective for improving working memory?
Research has shown mixed results for a technique called transcranial alternating current stimulation (tACS) in improving working memory. In this trial, participants will divide into two groups to receive different types of tACS. The Stimulation Theta Group will receive theta tACS, using low frequencies like 4 Hz, which has shown inconsistent effects in previous studies. Some studies found no improvement in memory, while others observed moderate benefits. Meanwhile, the Stimulation Beta Group will receive beta tACS, using higher frequencies like 23 Hz, which seems more promising. Several studies report that beta tACS improved working memory compared to no treatment. Overall, while tACS might help with memory, more research is needed to confirm its effectiveness.16789
Who Is on the Research Team?
Alexander Opitz, PhD
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for adults over 18 who can give their own consent and are undergoing phase II epilepsy surgical evaluation with implanted electrodes. It's not suitable for those unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive traveling wave transcranial alternating current stimulation to modify working memory performance and brain connectivity
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Alternating Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator